A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.

Proposals to give weight loss jabs to unemployed people living with obesity could be "very important" for our economy and health, the prime minister has told the BBC. Sir Keir Starmer said while he acknowledged that more money was needed for the NHS the government also needed to "think differently" to ease pressure on the health system.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Streeting announced a collaboration with the world's largest pharmaceutical company, Lilly, which will include a five-year trial investigating whether the use of the weight-loss drug tirzepatide helps get people back into employment.

BBC reporter Charlie Buckland explains what they are and how they work.

Weight loss and type 2 diabetes jabs could benefit people with alcohol abuse problems, according to a new study. Researchers found the common drugs led to a 50% lower rate of alcohol intoxication in people taking them compared to people not prescribed them.

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy.

Health secretary Wes Streeting announced weight loss injections could be used to get people living with obesity "back to work" at full capacity.

A study on the "real-world" effectiveness of weight loss drugs is set to measure the impact on the job prospects of people living with obesity in Greater Manchester. The five-year clinical trial was announced as part of a £279m plans by US pharmaceutical giant Eli Lilly to work with the UK government to address public health challenges like obesity.